Namibia has high HIV prevalence and migration rates, yet little is known about how migration affects HIV transmission. We assessed the impact of mobility on HIV transmission and treatment outcomes using data from the 2017 Namibia Population-based HIV Impact Assessment (NAMPHIA).
NAMPHIA included a nationally representative sample of adults aged 15–64 years. Recent infection (<130 days) was measured using HIV-1 LAg avidity combined with viral load (>1000 copies/mL) and antiretroviral (ARV) testing data. Awareness of HIV status and ARV use were based on self-report and/or detectable ARVs in blood. Viremia was defined as no viral load suppression (VLS, <1000 copies/ml) regardless of serostatus; community viremia was a weighted average across the sampled enumeration area. Ever migrants (EM) included those who had lived outside their home region, or away from home >1 month in the past 3 years. Recent in-migrants (RM) were those who moved to the community <2 years prior, even if this was an intra-regional move, compared to long-term in-migrants. Hazardous alcohol use was defined using the AUDIT-C scale. Analyses were run on weighted data.
Of eligible adults, 84% (9,671/11,510) of women and 73% (7,268/9,954) of men were interviewed and tested for HIV. Overall, 6.1% reported living outside Namibia, 52.5% had lived in another region, and 28.8% had lived away from home for >1 month, for a total of 62.5% of adults classified as EM; 15.3% of adults were RM. HIV prevalence was 12.6%, and did not differ by migration status; population VLS was 77.4%. RM was associated with recent HIV infection (adjusted odds ratio [aOR], 4.16; 95% confidence interval [CI]: 1.05–16.51) but only in communities with viremia >1%. Both EM and RM had lower proportions of VLS primarily due to less awareness of being HIV positive (Figure). If aware, there were no significant differences in proportion on ART for EM or RM. There was weak evidence that RM on ARVs had less VLS than long-term in-migrants (93% vs. 88%, p=0.059). On multivariable analysis, adjusted odds of VLS were low for RM (aOR, 0.57; 95% CI: 0.35–0.92) and for those with hazardous alcohol use (aOR, 0.29; 95% CI: 0.45–0.92).
Namibia has achieved a high level of population VLS. Understanding how to reach at-risk migrants with prevention and treatment can help further optimize the national HIV response.